nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—CYP3A4—Estropipate—osteoporosis	0.127	0.181	CbGbCtD
Tofisopam—CYP3A4—Calcitriol—osteoporosis	0.127	0.181	CbGbCtD
Tofisopam—CYP3A4—Ergocalciferol—osteoporosis	0.102	0.145	CbGbCtD
Tofisopam—CYP3A4—Raloxifene—osteoporosis	0.0849	0.121	CbGbCtD
Tofisopam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.082	0.117	CbGbCtD
Tofisopam—CYP3A4—Cholecalciferol—osteoporosis	0.0655	0.0934	CbGbCtD
Tofisopam—CYP3A4—Conjugated Estrogens—osteoporosis	0.0602	0.0858	CbGbCtD
Tofisopam—CYP3A4—Estradiol—osteoporosis	0.0528	0.0753	CbGbCtD
Tofisopam—PDE3A—GPCR downstream signaling—CALCR—osteoporosis	0.000985	0.0033	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTH1R—osteoporosis	0.000985	0.0033	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TLN1—osteoporosis	0.000976	0.00327	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—WNT1—osteoporosis	0.000964	0.00323	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VCL—osteoporosis	0.000963	0.00323	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—POMC—osteoporosis	0.000962	0.00323	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PTHLH—osteoporosis	0.00096	0.00322	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MGLL—osteoporosis	0.00094	0.00315	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CALCR—osteoporosis	0.000919	0.00308	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTH1R—osteoporosis	0.000919	0.00308	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LRP5—osteoporosis	0.000917	0.00307	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTH1R—osteoporosis	0.000896	0.003	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CALCR—osteoporosis	0.000896	0.003	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CALCR—osteoporosis	0.000894	0.003	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTH1R—osteoporosis	0.000894	0.003	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PTH—osteoporosis	0.000878	0.00294	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LRP6—osteoporosis	0.000877	0.00294	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PTHLH—osteoporosis	0.000871	0.00292	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000867	0.00291	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000856	0.00287	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CNR2—osteoporosis	0.000855	0.00287	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CALCA—osteoporosis	0.000845	0.00283	CbGpPWpGaD
Tofisopam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000817	0.00274	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RAP1A—osteoporosis	0.000804	0.0027	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—MGLL—osteoporosis	0.000804	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTH—osteoporosis	0.000797	0.00267	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—MGLL—osteoporosis	0.000782	0.00262	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CNR2—osteoporosis	0.000777	0.0026	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CALCA—osteoporosis	0.000767	0.00257	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TLN1—osteoporosis	0.000741	0.00248	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MGLL—osteoporosis	0.00073	0.00245	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—WNT1—osteoporosis	0.00073	0.00245	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—FGA—osteoporosis	0.00073	0.00245	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PTHLH—osteoporosis	0.000727	0.00244	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MGLL—osteoporosis	0.000712	0.00239	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MGLL—osteoporosis	0.00071	0.00238	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000703	0.00236	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LRP5—osteoporosis	0.000695	0.00233	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IGF1—osteoporosis	0.000673	0.00226	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LRP6—osteoporosis	0.000665	0.00223	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—FGB—osteoporosis	0.000664	0.00223	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTHLH—osteoporosis	0.00066	0.00221	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CALCA—osteoporosis	0.00064	0.00215	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—P4HB—osteoporosis	0.000639	0.00214	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000627	0.0021	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTH—osteoporosis	0.000621	0.00208	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RAP1A—osteoporosis	0.000611	0.00205	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CNR2—osteoporosis	0.000605	0.00203	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000601	0.00201	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SOST—osteoporosis	0.0006	0.00201	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NFATC1—osteoporosis	0.000596	0.002	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—DKK1—osteoporosis	0.000591	0.00198	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SOST—osteoporosis	0.000584	0.00196	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CALCA—osteoporosis	0.000581	0.00195	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—WNT1—osteoporosis	0.000569	0.00191	CbGpPWpGaD
Tofisopam—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000564	0.00189	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TLN1—osteoporosis	0.000561	0.00188	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FGA—osteoporosis	0.000554	0.00186	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—ADCY5—osteoporosis	0.000546	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTH1R—osteoporosis	0.000543	0.00182	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CALCR—osteoporosis	0.000543	0.00182	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PTH—osteoporosis	0.000532	0.00178	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTH1R—osteoporosis	0.000528	0.00177	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CALCR—osteoporosis	0.000528	0.00177	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CNR2—osteoporosis	0.000518	0.00174	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTH—osteoporosis	0.000517	0.00173	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—BMP2—osteoporosis	0.000515	0.00173	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTHLH—osteoporosis	0.000515	0.00173	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IGF1—osteoporosis	0.00051	0.00171	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CNR2—osteoporosis	0.000504	0.00169	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FGB—osteoporosis	0.000504	0.00169	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PSMA2—osteoporosis	0.000486	0.00163	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PSMA5—osteoporosis	0.000486	0.00163	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—P4HB—osteoporosis	0.000484	0.00162	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTH—osteoporosis	0.000483	0.00162	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTH—osteoporosis	0.000471	0.00158	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CNR2—osteoporosis	0.000471	0.00158	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTH—osteoporosis	0.00047	0.00157	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RAP1A—osteoporosis	0.000463	0.00155	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CNR2—osteoporosis	0.000459	0.00154	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CNR2—osteoporosis	0.000458	0.00153	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000456	0.00153	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—ADCY5—osteoporosis	0.000455	0.00153	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CALCA—osteoporosis	0.000453	0.00152	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NFATC1—osteoporosis	0.000451	0.00151	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00045	0.00151	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—DKK1—osteoporosis	0.000448	0.0015	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—WNT1—osteoporosis	0.000442	0.00148	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—POMC—osteoporosis	0.000442	0.00148	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PTHLH—osteoporosis	0.000441	0.00148	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MGLL—osteoporosis	0.000431	0.00145	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—WNT1—osteoporosis	0.000431	0.00145	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—WNT1—osteoporosis	0.00043	0.00144	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTHLH—osteoporosis	0.000429	0.00144	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LRP5—osteoporosis	0.000421	0.00141	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MGLL—osteoporosis	0.00042	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FGA—osteoporosis	0.00042	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ADCY5—osteoporosis	0.000414	0.00139	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KL—osteoporosis	0.000412	0.00138	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LRP5—osteoporosis	0.00041	0.00137	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—osteoporosis	0.000403	0.00135	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LRP6—osteoporosis	0.000403	0.00135	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—POMC—osteoporosis	0.000401	0.00135	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTHLH—osteoporosis	0.0004	0.00134	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LRP6—osteoporosis	0.000392	0.00131	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6R—osteoporosis	0.000392	0.00131	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTHLH—osteoporosis	0.00039	0.00131	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—BMP2—osteoporosis	0.00039	0.00131	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTHLH—osteoporosis	0.000389	0.0013	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CALCA—osteoporosis	0.000388	0.0013	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FGB—osteoporosis	0.000382	0.00128	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CALCA—osteoporosis	0.000377	0.00127	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000374	0.00125	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000369	0.00124	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PSMA5—osteoporosis	0.000369	0.00124	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PSMA2—osteoporosis	0.000369	0.00124	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000368	0.00123	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CALCA—osteoporosis	0.000352	0.00118	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CALCA—osteoporosis	0.000343	0.00115	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CALCA—osteoporosis	0.000343	0.00115	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TLN1—osteoporosis	0.00034	0.00114	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—POMC—osteoporosis	0.000335	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TLN1—osteoporosis	0.000331	0.00111	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ADCY5—osteoporosis	0.000322	0.00108	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SPP1—osteoporosis	0.000312	0.00105	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KL—osteoporosis	0.000312	0.00105	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—osteoporosis	0.000306	0.00102	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—POMC—osteoporosis	0.000304	0.00102	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF1—osteoporosis	0.000301	0.00101	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6R—osteoporosis	0.000297	0.000995	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—P4HB—osteoporosis	0.000293	0.000983	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTH—osteoporosis	0.000285	0.000956	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—P4HB—osteoporosis	0.000285	0.000956	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IRS2—osteoporosis	0.000282	0.000946	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAP1A—osteoporosis	0.00028	0.00094	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CNR2—osteoporosis	0.000278	0.000932	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTH—osteoporosis	0.000278	0.00093	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LEP—osteoporosis	0.000276	0.000925	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ADCY5—osteoporosis	0.000276	0.000925	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000274	0.000918	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NFATC1—osteoporosis	0.000274	0.000917	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAP1A—osteoporosis	0.000273	0.000914	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—DKK1—osteoporosis	0.000271	0.00091	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CNR2—osteoporosis	0.00027	0.000907	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ADCY5—osteoporosis	0.000268	0.0009	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NFATC1—osteoporosis	0.000266	0.000892	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—DKK1—osteoporosis	0.000264	0.000885	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ESR1—osteoporosis	0.000264	0.000884	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—WNT1—osteoporosis	0.000261	0.000876	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGA—osteoporosis	0.000254	0.000852	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—WNT1—osteoporosis	0.000254	0.000852	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ADCY5—osteoporosis	0.000251	0.00084	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGA—osteoporosis	0.000247	0.000829	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IRS1—osteoporosis	0.000246	0.000826	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ADCY5—osteoporosis	0.000244	0.000819	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ADCY5—osteoporosis	0.000244	0.000817	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—POMC—osteoporosis	0.000237	0.000795	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTHLH—osteoporosis	0.000236	0.000792	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—BMP2—osteoporosis	0.000236	0.000792	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SPP1—osteoporosis	0.000236	0.000792	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6R—osteoporosis	0.000231	0.000775	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGB—osteoporosis	0.000231	0.000775	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTHLH—osteoporosis	0.00023	0.000771	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—BMP2—osteoporosis	0.00023	0.000771	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF1—osteoporosis	0.000228	0.000765	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGB—osteoporosis	0.000225	0.000754	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PSMA5—osteoporosis	0.000223	0.000749	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PSMA2—osteoporosis	0.000223	0.000749	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000222	0.000744	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PSMA2—osteoporosis	0.000217	0.000728	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PSMA5—osteoporosis	0.000217	0.000728	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IRS2—osteoporosis	0.000214	0.000717	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LEP—osteoporosis	0.000209	0.000701	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CALCA—osteoporosis	0.000208	0.000698	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—POMC—osteoporosis	0.000203	0.00068	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CALCA—osteoporosis	0.000202	0.000679	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ESR1—osteoporosis	0.0002	0.00067	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—POMC—osteoporosis	0.000197	0.000662	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	0.000196	0.000658	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	0.000194	0.000649	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KL—osteoporosis	0.000189	0.000634	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IRS1—osteoporosis	0.000187	0.000626	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—POMC—osteoporosis	0.000184	0.000618	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KL—osteoporosis	0.000184	0.000616	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—osteoporosis	0.00018	0.000604	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6R—osteoporosis	0.00018	0.000603	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—POMC—osteoporosis	0.00018	0.000602	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—POMC—osteoporosis	0.000179	0.000601	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6R—osteoporosis	0.000175	0.000588	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6R—osteoporosis	0.000175	0.000586	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—osteoporosis	0.000174	0.000585	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF1—osteoporosis	0.000173	0.00058	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ADCY5—osteoporosis	0.000148	0.000496	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADCY5—osteoporosis	0.000144	0.000483	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SPP1—osteoporosis	0.000143	0.00048	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SPP1—osteoporosis	0.000139	0.000467	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—osteoporosis	0.000137	0.00046	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—osteoporosis	0.000137	0.000458	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—osteoporosis	0.000132	0.000443	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IRS2—osteoporosis	0.00013	0.000434	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LEP—osteoporosis	0.000127	0.000425	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IRS2—osteoporosis	0.000126	0.000422	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LEP—osteoporosis	0.000123	0.000413	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ESR1—osteoporosis	0.000121	0.000406	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—POMC—osteoporosis	0.000118	0.000395	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ESR1—osteoporosis	0.000118	0.000395	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IRS1—osteoporosis	0.000113	0.000379	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PKM—osteoporosis	0.000111	0.000373	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FDPS—osteoporosis	0.000111	0.000373	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IRS1—osteoporosis	0.00011	0.000369	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—POMC—osteoporosis	0.000109	0.000365	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6R—osteoporosis	0.000106	0.000356	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—POMC—osteoporosis	0.000106	0.000355	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPD2—osteoporosis	0.000105	0.000353	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PGLS—osteoporosis	0.000105	0.000353	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—osteoporosis	0.000105	0.000351	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—osteoporosis	0.000104	0.000348	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—osteoporosis	0.000104	0.000347	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6R—osteoporosis	0.000103	0.000346	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—osteoporosis	0.000103	0.000345	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—osteoporosis	0.000102	0.000342	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ATIC—osteoporosis	9.64e-05	0.000323	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PNP—osteoporosis	9.64e-05	0.000323	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA2—osteoporosis	8.2e-05	0.000275	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—OXCT1—osteoporosis	8.2e-05	0.000275	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—osteoporosis	8.01e-05	0.000269	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MGLL—osteoporosis	7.99e-05	0.000268	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—osteoporosis	7.81e-05	0.000262	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—osteoporosis	7.79e-05	0.000261	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—IDH2—osteoporosis	6.79e-05	0.000228	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.39e-05	0.000214	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—osteoporosis	6.29e-05	0.000211	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—osteoporosis	6.28e-05	0.00021	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ACP5—osteoporosis	6.21e-05	0.000208	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—osteoporosis	6.12e-05	0.000205	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—osteoporosis	6.11e-05	0.000205	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TPI1—osteoporosis	5.78e-05	0.000194	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—P4HB—osteoporosis	5.43e-05	0.000182	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GAPDH—osteoporosis	5.33e-05	0.000179	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—RAP1A—osteoporosis	5.19e-05	0.000174	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—osteoporosis	4.73e-05	0.000159	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—osteoporosis	4.6e-05	0.000154	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ENO1—osteoporosis	4.2e-05	0.000141	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PSMA5—osteoporosis	4.14e-05	0.000139	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PSMA2—osteoporosis	4.14e-05	0.000139	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.36e-05	0.000112	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ADCY5—osteoporosis	2.74e-05	9.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX1—osteoporosis	2.73e-05	9.16e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTHFR—osteoporosis	2.52e-05	8.45e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—POMC—osteoporosis	2.02e-05	6.76e-05	CbGpPWpGaD
